New Technologies for Immunotherapy
A special issue of Applied Sciences (ISSN 2076-3417). This special issue belongs to the section "Applied Biosciences and Bioengineering".
Deadline for manuscript submissions: 30 December 2026 | Viewed by 1209
Special Issue Editors
Interests: immunology; cytokines; reactive oxygen species; cell signalling; macrophages
Interests: immunology; infectious disease; parasitology
2. Center for Experimental Immunology and Immunobiology in Infectious Diseases and Cancer, University of Szczecin, Szczecin, Poland
Interests: animal models; viral infections; immune system; innate immunity; T cells; flow cytometry; real-time PCR
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The immune system is critical for the elimination of harmful stimuli (infectious or not) and for the return and maintenance of homeostasis within the body. On the other hand, dysregulated and/or excessive activation of immune responses can be a leading cause of tissue damage and disease. In this Special Issue, we welcome studies that underscore how the manipulation of the immune response, whether to improve its antimicrobial or antitumoral activity or to restrain its deleterious effects, can be used to treat infectious and non-infectious diseases. The submitted studies should provide new approaches and/or technologies for immunotherapies, including (i) combined therapies; (ii) cellular therapies; (iii) repositioning of pharmaceuticals; (iv) new molecular targets or approaches that allows for the discovery of inedit treatment modalities; and related issues.
Dr. Rafael Cardoso Maciel Costa Silva
Dr. Danielle Aparecida Sousa Rodrigues
Dr. Paulina Niedźwiedzka-Rystwej
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Applied Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- immunotherapy
- manipulation of immune responses
- inflammatory damage
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
